Business Context and Reporting Period
This Form 8-K Current Report from Nephros, Inc. covers events occurring on May 16, 2014, specifically the Company's 2014 Annual Meeting of Stockholders and a subsequent Board of Directors action.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and shareholder voting results rather than financial performance data.
Material Changes and Corporate Actions
Board of Directors Appointment
- Matthew Rosenberg was appointed to the Board of Directors on May 16, 2014.
- His initial term expires at the 2015 annual meeting of stockholders.
- He will receive standard compensation and indemnification for non-employee directors.
2014 Annual Meeting Results
- Election of Directors: Stockholders elected Daron Evans and Lawrence J. Centella to the Board for terms expiring in 2017.
- Daron Evans: 13,621,694 votes for; 440,571 withheld.
- Lawrence J. Centella: 13,615,627 votes for; 446,638 withheld.
- Auditor Ratification: Stockholders ratified the appointment of Rothstein Kass as the independent registered public accounting firm for the fiscal year ending December 31, 2014 (21,523,566 votes for; 140,348 against/withheld).
- Executive Compensation (Say-on-Pay): Stockholders approved the compensation of named executive officers in a non-binding advisory vote (13,699,548 votes for; 250,765 against/withheld).
- Compensation Vote Frequency: Stockholders approved holding future non-binding advisory votes on executive compensation once every two years (13,494,383 votes for the two-year option).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, specific risk factors, or contingencies. The document is limited to reporting the outcomes of the shareholder meeting and the new director appointment.
Key Facts for Investor Verification
- Verify the effective date and term length of Matthew Rosenberg's directorship.
- Confirm the ratification of Rothstein Kass as the independent auditor for the 2014 fiscal year.
- Note the shareholder decision to conduct executive compensation advisory votes biennially.
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the new director or meeting outcomes not detailed in the 8-K text.